INmune Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.
INMB Key Statistics
Stock Snapshot
With a market cap of 44.53M, INmune Bio(INMB) trades at $1.68. The stock has a price-to-earnings ratio of -0.79.
On 2026-01-26, INmune Bio(INMB) stock traded between a low of $1.63 and a high of $1.70. Shares are currently priced at $1.68, which is +2.6% above the low and -1.5% below the high.
INmune Bio(INMB) shares are trading with a volume of 164.84K, against a daily average of 366.29K.
In the last year, INmune Bio(INMB) shares hit a 52-week high of $11.64 and a 52-week low of $1.38.
In the last year, INmune Bio(INMB) shares hit a 52-week high of $11.64 and a 52-week low of $1.38.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.